This page shows the latest Moderna news and features for those working in and with pharma, biotech and healthcare.
There are also currently more than 1, 600 trials studying the therapy, including one evaluating it in combination with Merck and Moderna’s investigational skin cancer vaccine.
Moderna has announced a strategic partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate the development of vaccines against future viral disease outbreaks. ... CEPI researchers will send cutting-edge computational
The potential of the approach was brought to the fore during the COVID-19 pandemic and mRNA vaccines, including those from Moderna and Pfizer/BioNTech, have now been used globally to
The readout comes just a few weeks after Moderna announced promising results from a phase 1/2 trial of its own mRNA COVID-19/flu combination vaccine. ... Moderna has also said it is planning to begin a phase 3 trial of its candidate this year, adding
There are also currently more than 1, 600 trials studying the therapy, including one evaluating it in combination with Merck and Moderna’s investigational skin cancer vaccine.
number of doses of the Moderna vaccine, the researchers analysed the immunity that they had developed.
More from news
Approximately 98 fully matching, plus 163 partially matching documents found.
It has also signed strategic partnerships with Moderna and BioNTech, global leaders in this technology.
Meanwhile, at the bottom of the CXQ rankings, it’s perhaps not a surprise to see Moderna and BioNTech take the last and second-to-last slots respectively. ... navigating a still-changing commercial environment will have added to Moderna’s CX
The vaccine customer. One of the stories most embedded in the health crisis was from Moderna’s Darius Hughes. ... Overcoming that hurdle allowed Moderna to distribute some three million doses of its vaccine to patients in the UK within a month.
In the US, both Pfizer and Moderna worked with community organisations to increase representation in the COVID-19 vaccine trials.
Until the likes of Pfizer, AstraZeneca and Moderna started to have their coronavirus vaccines approved, the companies behind the medicines were rarely recognised by the public. ... The pharmaceutical and biotech company Moderna was virtually unknown to
More from intelligence
Approximately 1 fully matching, plus 14 partially matching documents found.
Horning has also recently joined the board of directors at Moderna, a clinical-stage biotechnology company based in Cambridge, Massachusetts.
Prior to this, he was chief scientific officer at Moderna Therapeutics and has held the same role at Tolerx.
Dr Slaoui takes on the role alongside his other board positions, which include chairman of the board at Galvani Bioelectronics, and on the boards of Artisan Biosciences, Moderna Therapeutics and Sutovax.
US-based biotech Moderna Therapeutics has appointed Israel Ruiz to its board of directors to serve as audit committee chair. ... Dr Noubar Afeyan, co-founder and chairman of Moderna Therapeutics, said: “We are delighted to welcome Israel to Moderna's
Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.
More from appointments
Approximately 3 fully matching, plus 6 partially matching documents found.
In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... With the emergency use authorisation and success of the Pfizer and
The following month, it happened again. Cambridge, Massachusetts-based Moderna said it had slowed enrolment in its phase 3 COVID-19 vaccine trial to ensure they were getting a representative population. ... Moderna effectively sacrificed potential sales,
15]. In fact, Moderna slowed down recruitment for its COVID-19 vaccine trial specifically to address a shortfall in recruitment from ethnically diverse populations for an illness that has been shown
Since then, other good news has followed, with collaborations, including Moderna and AstraZeneca, publishing similarly positive results. ... Since this initial announcement, other good news in vaccine development has followed, with companies and
In their latest blog, Hanover Brussels Alicia Rojo Santos and Pilar Serrano explores why the sector expecting to set off following the success of the Pfizer and Moderna SARS-CoV-2 ... Since then, other good news has followed, with collaborations,
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
No results were found
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...